top of page

biologit
Database

biologit Database, extensive range of global and local literature sources

At the heart of Biologit’s pharmacovigilance solutions is our state-of-the-art database, built to revolutionise how indexed and non-indexed literature is monitored to identify safety events. Engineered to meet the demands of modern pharmacovigilance, our database integrates real-time intake of huge volumes of scientific and medical literature.​

Group 11.png

The biologit Database offers unparalleled coverage, including MEDLINE as recommended regulatory authorities, and vast additional scope to ensure rigorous access and compliance for safety screening.​

Group 13.png

Global Literature Monitoring

The Biologit database is a comprehensive and continuously updated repository of scientific literature, used by organisations around the globe from clinical development to post market. It supports compliant regulatory searches, aggregating all relevant sources via an easy-to use interface.

Extensive global coverage, including MEDLINE

Complies with global regulatory requirements for pharmacovigilance and medical device safety screening

Available on-demand from the biologit Platform

Updated daily

global database
local databse

Local Literature Monitoring

Unique and the most extensive source of indexed and non-indexed literature sources of from across the world.

Large open source regional repositories; over 120,000 sources not available on MEDLINE or Embase

World-first managed service product to ingest any local literature source

100% coverage: All required non-indexed sources (websites, print journals) are procured by Biologit

Fully managed: Built-in governance and quality processes, integrated with the Biologit Platform for for seamless regulatory workflows

entries

65+ Million

Entries

entries daily

40,000

New entries daily

journals

140,000

Journals

countries

170+

Countries 

Download our White Paper​

Learn more about our world-first product to drive automation in local literature monitoring. Biologit for Local Literature solves the costly and complex problem of how to reliably identify adverse events and relevant safety information across the full spectrum of local literature sources, including non-indexed and hard-to-access country publications.

download white paper

Key Features

Biologit data includes multilingual drug and device names, synonyms and relevant terms

Integration Machine translation for abstracts and full text, and access to open source full text

Machine Learning and Natural Language Process to accurately find and screen safety information 

Multiple source types including indexed and non-indexed journals, websites and print

Access to open source full text articles

Multilingual data from emerging and underrepresented markets to provide a truly global perspective on safety

Advanced search capabilities and programatic access to the data

Interested in our coverage?

Contact us to access the the list of journals and conferences available on biologit database.

get in touch
bottom of page